Dr. VANDENWEGHE Kristof, Algemene Geneeskunde
0847.273.521 · rovalta.com · 28/09/2026
Dr. VANDENWEGHE Kristof, Algemene Geneeskunde
Financial year 2023 · Closed on 31/12/2023
Overview
Identity
Source · BCE/KBODr. VANDENWEGHE Kristof, Algemene Geneeskunde is a Private company with limited liability incorporated in 2012. Its registered office is in Leuven.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0847.273.521
- Incorporation
- 03/07/2012
- Legal form
- Private company with limited liability
- Registered office
- Heidebergstraat 254
3010 Leuven · FlandreSee on map - Contributed capital
- 12 400,00 €
- Latest accounts
- 31/12/2023
Financials
Source · NBB, 12 filingsTrend over 11 financial years
| 2023 | 2022 | 2021 | 2020 | 2019 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | -2,3 k € | +79.9% | -11,6 k € | – | -2,7 k € | -1713% | -150,6 € | ||
| EBITDA | -3,2 k € | +79.2% | -15,2 k € | -5898% | -253 € | +93.2% | -3,7 k € | -470% | -655,8 € |
| Operating result | -3,2 k € | +87.6% | -25,4 k € | -143% | -10,5 k € | +25.0% | -13,9 k € | -28.3% | -10,9 k € |
| Net result | -3,2 k € | +87.7% | -25,8 k € | -147% | -10,5 k € | +27.3% | -14,4 k € | -25.5% | -11,5 k € |
| Balance sheet | |||||||||
| Equity | -65,5 k € | -5.1% | -62,3 k € | -70.8% | -36,5 k € | -40.2% | -26 k € | -124% | -11,6 k € |
| Total assets | 798,3 € | +10.1% | 725,3 € | -93.4% | 11 k € | -48.1% | 21,2 k € | -30.8% | 30,7 k € |
| Cash | 80,9 € | +930% | 7,9 € | -92.9% | 111,3 € | -0.5% | 111,8 € | +287% | 28,9 € |
| Debts | 66,3 k € | +5.2% | 63 k € | +32.7% | 47,5 k € | +0.5% | 47,2 k € | +11.7% | 42,3 k € |
Board of directors
Source · NBB, accounts to 31/12/20231 active
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
Kristof Vandenweghe | DirectorMandateendedManagerended |
Other companies at this address
Heidebergstraat 254 3010 Leuven| Company | CBE no. |
|---|---|
K& M HOLDING● Active | 0890.056.855 |
Financials
Full financial information
Source · NBB| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Micro model |
| Start of the financial year | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 | 01/01/2019 |
| Closing of the financial year | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 14/12/2025 | 30/08/2024 | 30/08/2023 | 30/08/2022 | 27/10/2021 | 12/11/2020 |
| General meeting | 01/05/2025 | 31/05/2024 | 15/06/2023 | 01/05/2022 | 17/06/2021 | 18/06/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 12 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2024 | 01/05/2025 | 14/12/2025 | Dutch | |
| Abridged model | 31/12/2023 | 31/05/2024 | 30/08/2024 | Dutch | |
| Abridged model | 31/12/2022 | 15/06/2023 | 30/08/2023 | Dutch | |
| Abridged model | 31/12/2021 | 01/05/2022 | 30/08/2022 | Dutch | |
| Abridged model | 31/12/2020 | 17/06/2021 | 27/10/2021 | Dutch | |
| Micro model | 31/12/2019 | 18/06/2020 | 12/11/2020 | Dutch | |
| Micro model | 31/12/2018 | 20/06/2019 | 22/08/2019 | Dutch | |
| Micro model | 31/12/2017 | 21/06/2018 | 31/08/2018 | Dutch | |
| Micro model | 31/12/2016 | 15/06/2017 | 27/09/2017 | Dutch | |
| Abridged model | 31/12/2015 | 16/06/2016 | 31/08/2016 | Dutch | |
| Abridged model | 31/12/2014 | 19/06/2015 | 05/10/2015 | Dutch | |
| Abridged model | 31/12/2013 | 19/06/2014 | 28/08/2014 | Dutch |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20231 active
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
Kristof Vandenweghe | DirectorMandateendedManagerended |
Ownership and network
Looking for more information about this company?
Try for freePublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsRegistered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Heidebergstraat 254, 3010 Kessel-loCurrent | accounts 2021 → 2023 | Accounts 2023 · 2024-00425792 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| Dr. VANDENWEGHE Kristof, Algemene GeneeskundeCurrent | CBE | |
| Dr. Vandenweghe Kristof bv | accounts 2021 → 2023 | Accounts 2023 · 2024-00425792 |
| Dr. VANDENWEGHE Kristof, Algemene Geneeskunde | accounts 2013 → 2020 | Accounts 2020 · 2021-73900052 |
Events
- 2023Annual accounts 2023-3,2 k €↑
- 2022Annual accounts 2022-25,8 k €↓
- 2021Annual accounts 2021-10,5 k €↑
- 2021Name changeDr. Vandenweghe Kristof bv
- 2020Annual accounts 2020-14,4 k €↓
- 2019Annual accounts 2019-11,5 k €↑
- 2018Annual accounts 2018-13,5 k €↓
- 2017Annual accounts 2017-379,2 €↓
- 2016Annual accounts 2016645,5 €↑
- 2015Annual accounts 2015540,1 €↑
- 2014Annual accounts 2014117 €↑
- 2013Annual accounts 201327,5 €
- 03/07/2012IncorporationPrivate company with limited liability